Navigating IP Tech Transfer Webinar

September 18, 2024

2:00 PM ET / 11:00 AM PT

Register Here

Dr. Jonathan Soderstrom

Chief Licensing Advisor at Wilson Sonsini Goodrich & Rosati

Karl Pawlik

CFO & Vertical Lead Life Sciences at Escalon.Services

Unlock the Full Potential of Your Tech Transfer Agreement

Ensure Your Business Thrives with the Right Deal

A tech transfer agreement can significantly impact the future of your business. Our expert discussion by our Vertical Lead, Karl Pawlik, is designed to guide you towards success, whether you’re just starting out or need help correcting a bad deal.

What You’ll Learn:

  • Where to Start: Get the right foundation for your tech transfer efforts and set yourself up for success.
  • Preparing for Negotiations: Learn how to prepare for and approach negotiations to achieve the best possible outcome.
  • Crafting the Perfect Deal: Understand what a good tech transfer deal looks like and the steps you need to take to get there.
  • Avoiding and Fixing Red Flags: Identify potential issues early and learn strategies to correct a bad deal.

Don’t leave your business’s future to chance. Start your journey towards a successful tech transfer agreement today!

Register Here

Meet our speakers

Dr. Jonathan Soderstrom

Dr. Jonathan Soderstrom is a chief licensing advisor in the New York office of Wilson Sonsini Goodrich & Rosati. He is also a member of the technology transactions and the patents and innovations practice groups. Jon has spent over 40 years managing the commercialization of intellectual property created at major public and private research institutions.

Karl Pawlik

Karl Pawlik leads our Life Science practice at Escalon Services. Karl has over 20 years of experience working in various leadership roles in finance, accounting, and strategy, with the last 10+ years being dedicated to the role of CFO of venture and pre-venture funded start-ups. Earlier in his career, Karl held global finance, business development, and strategy roles with Fortune 500 companies including Applied Materials, and St. Jude Medical (now Abbott), where he was part of the team that acquired CardioMeMs and NanoStim.